Skip to content

Recurrence of Trigeminal Neuralgia in Patient's Undergoing Radiofrequency Ablation

Recurrence Rate of Trigeminal Neuralgia in Patients Treated With Percutaneous Stereotactic Continuous Radiofrequency Rhizotomy at 80 Degrees Celsius for 90 Seconds- a Single Center Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05101577
Enrollment
56
Registered
2021-11-01
Start date
2016-09-01
Completion date
2021-10-20
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia, Idiopathic

Keywords

trigeminal neuralgia, stereotactic rhizotomy, radiofrequency ablation, recurrence

Brief summary

This study aims to find recurrence rate of the trigeminal neuralgia after patients undergo stereotactic rhizotomy by radiofrequency ablation at 80 degrees Celsius for 90 seconds under fluoroscopic guidance, a protocol that was modified from the originally described parameters for rhizotomy by John Tew, Chad J. Morgan and Andresw Grande et al. The presumption being that the higher temperature of the probe tip would lead to a more long-lasting lesion and lesser recurrence, but at the cost of more frequent sensory and motor deficits.

Interventions

None listed

Sponsors

Shifa Clinical Research Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
27 Years to 91 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\. Patients fulfilling ICHD criteria: Recurrent paroxysms of unilateral facial pain in the distribution(s) of one or more divisions of the trigeminal nerve, with no radiation beyond, and fulfilling criteria B and C A. Pain has all of the following characteristics: 1. lasting from a fraction of a second to 2 minutes 2. severe intensity 3. electric shock-like, shooting, stabbing or sharp in quality B. Precipitated by innocuous stimuli within the affected trigeminal distribution C. Not better accounted for by another ICHD-3 diagnosis. 2\. Age: Adults of both sexes 3. MRI brain ruled out organic or structural pathologies

Exclusion criteria

* 1\. Patient with concomitant co-morbid conditions like brain tumours, vascular pathologies or coagulopathies. 2\. Patients who had previously undergone trigeminal ganglion neurolysis with either alcohol or phenol. 3\. Patients who were lost to follow-up before the completion of 6-month period or had not visited back after the procedure 4. Patients on oral anticoagulants 5. Patients declared high risk or ASA 3 and above for general anaesthesia.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence rate of trigeminal neuralgia after stereotactic rhizotomyRecurrence within 12 months of the interventionRecurrence of pain in the same distribution of the trigeminal nerve branch or branches for which the stereotactic rhizotomy was originally performed
Proportion of patients with neurological deficits after stereotactic rhizotomy5 yearslocally deviced protocol for stereotactic rhizotomy of the involved trigeminal gangion dictates the use of higher temperature of 80 degree Celsius for 90 seconds, which translates into better pain relief and longer pain free intervals at the cost of higher percentage of sensory and motor deficits

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026